Brinzolamide 1/timolol 0.5: Safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma

Current Medical Research and Opinion

Volumn 26, Issue 11, 2010, Pages 2575-2578

  Januleviciene, Ingrida ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Brinzolamide; Dorzolamide; Drug combinations; Glaucoma; Intraocular pressure; Timolol

Indexed keywords

BRINZOLAMIDE; BRINZOLAMIDE PLUS TIMOLOL; DORZOLAMIDE PLUS TIMOLOL; TIMOLOL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; BLURRED VISION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DYSGEUSIA; EYE DISCOMFORT; EYE IRRITATION; EYE PAIN; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PATIENT COMPLIANCE; SIDE EFFECT; SORE THROAT;

ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; DRUG THERAPY, COMBINATION; DRUG TOXICITY; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; SULFONAMIDES; THIAZINES; TIMOLOL; TREATMENT OUTCOME;

EID: 77958150012     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.517718     Document Type: Article

References (17)

1. Hutzelmann J, Owens S, Shedden A, et al. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol 1998; 82:1249-53
2. COSOPT [package insert]. Whitehouse Station, NJ: Merck & Co., Inc., 2006
3. Nii H, Ikeda H, Okada K, et al. Circadian change of adenylate cyclase activity in rabbit ciliary processes. Curr Eye Res 2001;23:248-55
4. Sherwood MB, Craven ER, Chou C, et al. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Arch Ophthalmol 2006;124:1230-8
5. Azarga [package insert]. Puurs, Belgium: Alcon Laboratories, Inc., 2008
6. Kaback M, Scoper SV, Arzeno G, et al. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. Ophthalmology 2008;115: 1728-34
7. Manni G, Denis P, Chew P, et al. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 2009;18:293-300
8. Vold SD, Evans RM, Stewart RH, et al. A one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertension. J Ocul Pharm Ther 2008;24:601-5
9. Mundorf TK, Rauchman SH, Williams RD, et al. A patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzo-lamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol 2008;2:623-8
10. Siesky B, Harris A, Cantor LB, et al. A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular micro-circulation in patients with primary open-angle glaucoma. Br J Ophthalmol 2008;92:500-4
11. Harris A, Siesky B, Shoshani Y, et al. Predictors for visual field progression. Acta Ophthalmol. 2010;88:504-5
12. Holló G. Brinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertension. Expert Rev Ophthalmol 2009;4:129-33
13. Chan K, Testa M, McCluskey P. Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%. J Ocul Pharmacol Ther 2007;23:372-6
14. Barnebey H, Kwok SY. Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. Clin Ther 2000;22:1204-12
15. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma 2003;12:393-8
16. Silva LR, de Paula JS, Rocha EM, et al. Factors related to glaucoma treatment compliance: patients' opinions from a University Hospital. Arq Bras Oftalmol 2010;73:116-19
17. Bloch S, Rosenthal AR, Friedman L, et al. Patient compliance in glaucoma. Br J Ophthalmol 1977;61:531-4